18 results
424B3
SEEL
Seelos Therapeutics Inc
15 Mar 24
Prospectus supplement
4:15pm
, preclinical studies, supply chain and operations;
risks and uncertainties associated with our actual and proposed research and development activities
424B5
SEEL
Seelos Therapeutics Inc
30 Jan 24
Prospectus supplement for primary offering
6:05am
, including disruptions to our clinical trials, preclinical studies, supply chain and operations;
risks and uncertainties associated with our actual
424B5
SEEL
Seelos Therapeutics Inc
30 Nov 23
Prospectus supplement for primary offering
4:58pm
to our business, financial condition and employees, including disruptions to our clinical trials, preclinical studies, supply chain and operations
424B5
5ynl146et2yevsi
28 Nov 23
Prospectus supplement for primary offering
4:06pm
424B5
omkueel9m0sz hztzl
25 Sep 23
Prospectus supplement for primary offering
6:02am
424B5
54iry4qpvn
12 May 22
Prospectus supplement for primary offering
8:30am
424B5
av5p y2y6fe
21 May 21
Prospectus supplement for primary offering
12:00am
424B5
nls93
19 May 21
Prospectus supplement for primary offering
4:08pm
424B5
eds2ta
26 Jan 21
Prospectus supplement for primary offering
5:11pm
424B5
otr1u58jsa
25 Jan 21
Prospectus supplement for primary offering
4:16pm
424B3
ifsb55o
4 Dec 20
Prospectus supplement
4:48pm
424B5
klkm4fb3
8 Sep 20
Prospectus supplement for primary offering
4:43pm
8-K
EX-10.1
4a06wj
20 Oct 14
Apricus Expands Development Pipeline
12:00am
- Prev
- 1
- Next